The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 1
  • Portal, Thibaud, Dr
    Ceo born in November 1970
    Individual (4 offsprings)
    Officer
    2021-07-30 ~ now
    OF - Director → CIF 0
Ceased 4
  • 1
    Ollier, Michele
    Partner At Medixci Ventures born in June 1958
    Individual (7 offsprings)
    Officer
    2021-09-15 ~ 2024-01-27
    OF - Director → CIF 0
  • 2
    De Rubertis, Francesco
    Investor born in January 1970
    Individual (19 offsprings)
    Officer
    2022-12-07 ~ 2024-01-27
    OF - Director → CIF 0
  • 3
    Prausnitz, Mark, Dr
    Professor born in February 1966
    Individual
    Officer
    2021-07-30 ~ 2024-01-27
    OF - Director → CIF 0
  • 4
    ALDENA THERAPEUTICS (UK) LTD
    C/o Goodwin Proctor Llp, 100 Northern Avenue, Boston, Ma 02210, United States
    Active Corporate (1 parent)
    Equity (Company account)
    -10,576,901 GBP2023-12-31
    Person with significant control
    2021-07-30 ~ 2024-12-31
    PE - Ownership of shares – 75% or moreCIF 0
    PE - Ownership of voting rights - 75% or moreCIF 0
parent relation
Company in focus

ALDENA THERAPEUTICS (UK) LTD

Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
42023-01-01 ~ 2023-12-31
32021-07-30 ~ 2022-12-31
Debtors
Current
465,333 GBP2023-12-31
105,574 GBP2022-12-31
Cash at bank and in hand
383,051 GBP2023-12-31
1,157,422 GBP2022-12-31
Current Assets
848,384 GBP2023-12-31
1,262,996 GBP2022-12-31
Creditors
Current, Amounts falling due within one year
-11,425,285 GBP2023-12-31
-5,073,665 GBP2022-12-31
Net Current Assets/Liabilities
-10,576,901 GBP2023-12-31
-3,810,669 GBP2022-12-31
Total Assets Less Current Liabilities
-10,576,901 GBP2023-12-31
-3,810,669 GBP2022-12-31
Net Assets/Liabilities
-10,576,901 GBP2023-12-31
-3,810,669 GBP2022-12-31
Equity
Called up share capital
1 GBP2023-12-31
1 GBP2022-12-31
Retained earnings (accumulated losses)
-10,576,902 GBP2023-12-31
-3,810,670 GBP2022-12-31
Equity
-10,576,901 GBP2023-12-31
-3,810,669 GBP2022-12-31
Trade Debtors/Trade Receivables
Current
134,039 GBP2023-12-31
60,850 GBP2022-12-31
Other Debtors
Current
56,537 GBP2023-12-31
44,724 GBP2022-12-31
Prepayments/Accrued Income
Current
274,757 GBP2023-12-31
Trade Creditors/Trade Payables
Current
1,516,278 GBP2023-12-31
333,762 GBP2022-12-31
Amounts owed to group undertakings
Current
9,585,484 GBP2023-12-31
4,684,157 GBP2022-12-31
Accrued Liabilities/Deferred Income
Current
323,523 GBP2023-12-31
55,746 GBP2022-12-31
Creditors
Current
11,425,285 GBP2023-12-31
5,073,665 GBP2022-12-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
100 shares2023-12-31
100 shares2022-12-31
Par Value of Share
Class 1 ordinary share
0.012023-01-01 ~ 2023-12-31

Related profiles found in government register
  • ALDENA THERAPEUTICS (UK) LTD
    Info
    Registered number 13540917
    2nd Floor 168 Shoreditch High Street, London E1 6RA
    Private Limited Company incorporated on 2021-07-30 (3 years 11 months). The company status is Active.
    The last date of confirmation statement was made at 2025-03-20
    CIF 0
  • ALDENA THERAPEUTICS, INC
    S
    Registered number Usa
    C/o Goodwin Proctor Llp, 100 Northern Avenue, Boston, Ma 02210, United States
    Private Company Limited By Shares in Usa
    CIF 1
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
Ceased 1
  • 2nd Floor 168 Shoreditch High Street, London, United Kingdom
    Active Corporate (1 parent)
    Equity (Company account)
    -10,576,901 GBP2023-12-31
    Person with significant control
    2021-07-30 ~ 2024-12-31
    CIF 1 - Ownership of shares – 75% or more OE
    CIF 1 - Ownership of voting rights - 75% or more OE
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.